A man from Quebec, aged 64, has become the pioneer patient in North America to undergo a liver transplant involving a regenerated liver. This innovative technology has the potential to significantly increase the availability of transplantable livers, with projections indicating that up to 24 additional livers could be made available for transplantation in the first year alone.
The recipient, Gérard Landry, residing in Nouvelle on Quebec’s Gaspé Peninsula, had been grappling with liver issues for around 15 years, which eventually led to cirrhosis and liver cancer. Prior to his surgery at Montreal’s Centre hospitalier de l’Université de Montréal (CHUM), Landry received surprising news from his doctor that his liver had been regenerated using a novel machine.
The groundbreaking technology, known as Liver Assist, enables medical professionals to assess and treat a donated liver outside the body before transplantation. This advancement allowed Landry to receive a liver that might have been deemed too risky for conventional use.
Dr. David Hénault, a liver transplant specialist at CHUM who spearheaded the project and conducted Landry’s surgery, highlighted that the team had been preparing to utilize the technology for approximately three years. The Liver Assist system functions by connecting a donated liver to a machine circulating an oxygen-rich fluid through it, aiding in reversing damage caused by oxygen deprivation during the organ’s extracorporeal period.
According to Hénault, the technology facilitates the transition to a blood-based solution for assessing liver function under conditions simulating the human body. By applying this method, doctors can ascertain the organ’s viability for transplantation.
The CHUM performs about 70 liver transplants annually, and a collaborative study with Transplant Québec identified livers previously declined for transplantation that could potentially be salvaged using the new technology. The team anticipates that the machine could enhance the pool of available livers by 20 to 24 in its inaugural year, with the potential for further expansion as the technology gains wider adoption.
Notably, studies have indicated that the technology may reduce complications, reoperations, and hospital stays for suitable candidates. Landry’s post-transplant progress demonstrated promising signs, with his blood work showing better-than-expected results just a day after the operation.
As Landry continues his recovery in Montreal, with periodic hospital visits for monitoring, he looks forward to returning to Gaspésie. Reflecting on his experience, he hopes to inspire conversations about organ donation, emphasizing the critical need for donated organs to complement even the most advanced medical technologies. For Landry, the importance of organ donation is akin to having a horse without a rider—a vital partnership for a successful journey.
